Loading cancer entity…
Loading cancer entity…
Clinical trials
6,746 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,045)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01000480 | A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer | completed | Phase 2 | 90 | Eli Lilly and CompanyINDUSTRY | 4 | Apr 2, 2014 | clinicaltrials |
| NCT00085280 | Erlotinib in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | completed | N/A | 129 | National Cancer Institute (NCI)NIH | 1 | Mar 31, 2014 | clinicaltrials |
| NCT01772225 |
| NSCLC Burden of Illness Study(LuCaBIS) |
| completed |
| — |
| 1 |
| GlaxoSmithKlineINDUSTRY |
| 0 |
| Mar 31, 2014 |
| clinicaltrials |
| NCT00730925 | Single-arm Trial of BIBW 2992 (Afatinib) in Demographically and Genotypically Selected NSCLC Patients | completed | Phase 2 | 41 | Boehringer IngelheimINDUSTRY | 2 | Mar 26, 2014 | clinicaltrials |
| NCT00247416 | Effects of Carboplatin and Gemcitabine on Stage IIIB Pleural Effusion and Stage IV Lung Cancer | completed | Phase 2 | 60 | Susanne ArnoldOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00476216 | Fondaparinux (Arixtra) With Chemotherapy for Advanced Non-Small Cell Lung Cancer | completed | Phase 1 | 23 | University of Alabama at BirminghamOTHER | 1 | Mar 5, 2014 | clinicaltrials |
| NCT00091663 | A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 5,000 | Genentech, Inc.INDUSTRY | 1 | Mar 4, 2014 | clinicaltrials |
| NCT00995761 | Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 48 | Gyeongsang National University HospitalOTHER | 1 | Mar 3, 2014 | clinicaltrials |
| NCT01465243 | Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose | completed | Phase 4 | 32 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT01516983 | Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation | completed | Phase 1 / Phase 2 | 15 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 17, 2014 | clinicaltrials |
| NCT01040780 | Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients(ICOGEN) | completed | Phase 3 | 399 | Betta Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00256789 | Once Weekly Radiation for Lung Cancer With Chemotherapy | completed | N/A | 26 | Clinical Oncology Research AssociatesOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00256815 | Combination of Weekly Chest Radiotherapy and Oral Navelbine for the Palliation of Advanced Non Small Cell Lung Cancer: A Phase I Study | completed | Phase 1 / Phase 2 | 35 | Clinical Oncology Research AssociatesOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00171834 | Dose Escalating Study of the Safety and Efficacy of Patupilone, q3w, in Patients With Non-small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 89 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 5, 2014 | clinicaltrials |
| NCT00390806 | Oral HYCAMTIN Plus Whole Brain Radiation Therapy In Treatment Of Brain Metastases Resulting From Non-Small Lung Cancer | completed | Phase 3 | 472 | GlaxoSmithKlineINDUSTRY | 6 | Jan 20, 2014 | clinicaltrials |
| NCT00246181 | Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC(SBF-NSCLC) | completed | Phase 1 / Phase 2 | 117 | Jill DelucaOTHER | 1 | Jan 13, 2014 | clinicaltrials |
| NCT00487669 | Phase II Study of Combination of Paclitaxel Poliglumex and Alimta for Advanced Non-small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 14 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT01003899 | A Phase II Trial of Afatinib(BIBW 2992) in Third-line Treatment for Patients With Stage IIIB/IV Adenocarcinoma of the Lung Harbouring Wild-type Epidermal Growth Factor Receptor[EGFR] | completed | Phase 2 | 43 | Boehringer IngelheimINDUSTRY | 1 | Dec 31, 2013 | clinicaltrials |
| NCT00883675 | Safety Study of Adjuvant Docetaxel-Carboplatin Treatment for Resected Lung Cancer | completed | Phase 4 | 133 | Michael MannNETWORK | 2 | Dec 18, 2013 | clinicaltrials |
| NCT01741636 | Survivorship Care Planning in Patients With Colorectal or Non-Small Cell Lung Cancer | completed | N/A | 30 | City of Hope Medical CenterOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT01005680 | A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 256 | Eli Lilly and CompanyINDUSTRY | 1 | Dec 13, 2013 | clinicaltrials |
| NCT00717002 | Detection of EGFR Mutations in the Blood of Patients With Non-small Cell Lung Cancer: a Feasibility Study | completed | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00717847 | A Study of Serum Protein Profiling in Patients With Non-Small Cell Lung Cancer Treated With Gefitinib or Erlotinib | completed | — | — | National University Hospital, SingaporeOTHER | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00762346 | Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone Metastasis | completed | Phase 4 | 156 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00765687 | Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates(BLEST) | completed | Phase 4 | 432 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01017679 | Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mg | completed | Phase 2 | 96 | Sun Yat-sen UniversityOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT01561456 | Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung | completed | Phase 2 | 100 | Axelar ABINDUSTRY | 5 | Dec 5, 2013 | clinicaltrials |
| NCT01069328 | Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC) | completed | Phase 1 | 33 | BayerINDUSTRY | 1 | Nov 13, 2013 | clinicaltrials |
| NCT00600821 | A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer. | completed | Phase 2 | 118 | PfizerINDUSTRY | 6 | Nov 8, 2013 | clinicaltrials |
| NCT00322452 | First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia(IPASS) | completed | Phase 3 | 1,329 | AstraZenecaINDUSTRY | 9 | Nov 7, 2013 | clinicaltrials |
| NCT00828841 | Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC | completed | Phase 2 | 601 | Accelerated Community Oncology Research NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT01528488 | Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLC | completed | Phase 2 / Phase 3 | 118 | Sun Yat-sen UniversityOTHER | 1 | Nov 5, 2013 | clinicaltrials |
| NCT00870532 | Study of Combination of Metronomic Oral Vinorelbine and Sorafenib in Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 1 | 52 | National Cancer Centre, SingaporeOTHER | 1 | Nov 4, 2013 | clinicaltrials |
| NCT00101413 | BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC) | completed | Phase 2 | 52 | BayerINDUSTRY | 2 | Oct 30, 2013 | clinicaltrials |
| NCT00147537 | Combination Study Of CP-751,871 With Paclitaxel And Carboplatin In Advanced Lung Cancer | completed | Phase 1 / Phase 2 | 282 | PfizerINDUSTRY | 4 | Oct 30, 2013 | clinicaltrials |
| NCT00457392 | A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone | completed | Phase 3 | 960 | PfizerINDUSTRY | 26 | Oct 29, 2013 | clinicaltrials |
| NCT00636571 | Feasibility of Exercise With Post-Op Lung Cancer Patients | completed | N/A | 21 | Duke UniversityOTHER | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00997230 | Epidemiological and Scientific Evaluation of EGFR Mutation Status in Patients With Newly Diagnosed Locally Advanced or m(REASON) | completed | — | 4,243 | AstraZenecaINDUSTRY | 1 | Oct 28, 2013 | clinicaltrials |
| NCT00132522 | EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide | completed | Phase 1 | 45 | EMD SeronoINDUSTRY | 2 | Oct 25, 2013 | clinicaltrials |
| NCT00298415 | Chemotherapy of Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC) | completed | Phase 3 | 451 | Intergroupe Francophone de Cancerologie ThoraciqueOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT00413283 | Dose/ Schedule Finding Trial of Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT) in Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 2 | 63 | AmgenINDUSTRY | 8 | Oct 24, 2013 | clinicaltrials |
| NCT00633529 | Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC | completed | Phase 1 | 36 | EMD SeronoINDUSTRY | 1 | Oct 22, 2013 | clinicaltrials |
| NCT00243347 | The Effects of AZD2171 in Patients With Non-Small Cell Lung Cancer or Head & Neck Cancer | completed | Phase 1 | 19 | AstraZenecaINDUSTRY | 2 | Oct 17, 2013 | clinicaltrials |
| NCT01956331 | Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer(OPERAGE) | completed | — | 302 | Groupe Francais De Pneumo-CancerologieOTHER | 1 | Oct 8, 2013 | clinicaltrials |
| NCT00418704 | Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC) | completed | — | 100 | Groupe Francais De Pneumo-CancerologieOTHER | 1 | Oct 1, 2013 | clinicaltrials |
| NCT00419042 | Elderly Dependent Patients With Non Small Cell Lung Cancer (NSCLC) | completed | — | 100 | Groupe Francais De Pneumo-CancerologieOTHER | 1 | Oct 1, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00084981 | Decitabine and Valproic Acid in Treating Patients With Non-Small Cell Lung Cancer | completed | Phase 1 | 25 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 2, 2014source: clinicaltrials